Neuropathic pain is caused by a lesion or disease affecting the somatosensory system and is difficult to manage, often proving refractory to existing treatments. In more than half of cases, it is localised and affects a specific, clearly circumscribed area of the body (localised neuropathic pain, or LNP). A recently developed screening tool enables patients with probable neuropathic pain/LNP to be identified quickly and easily. In view of the conflicting current treatment recommendations, an advisory board of pain specialists met in June 2015 to develop a complementary treatment guidance algorithm, for use in the primary care setting and by non-pain specialists. The starting point of the algorithm is a diagnosis of LNP and there was consensus that first-line treatment should be a topical analgesic agent, because the benefit/risk ratios are far better than for systemic agents. Topical application offers site-specific delivery, a lower total systemic dose and avoidance of first-pass metabolism, reducing the risk of adverse events and drug/drug interactions. The 5% lidocaine medicated plaster has most evidence supporting its use in LNP, producing effective analgesia and reducing the associated area of allodynia, but other topical agents include capsaicin, clonidine and botulinum toxin type A. Treatment should be commenced with the topical agent of choice, and the patient re-assessed after an appropriate period. Where the response is good the topical agent is continued, with a re-evaluation after 3 to 6 months. A systemic agent (e.g. gabapentin, pregabalin, duloxetine, venlafaxine) is added if there is only a partial response, or substituted if there is no response, and the patient re-assessed after a month. If there is a poor or no response to the systemic agent the patient should be switched to an alternative one, and if this also proves ineffective referred to a pain specialist.

A pharmacological treatment algorithm for localised neuropathic pain [LNP] / Allegri, Massimo; Baron, Ralf; Hans, Guy; Correa Illanes, Gerardo; Mayoral Rojals, Victor; Mick, Gerard; Serpell, Michael. - In: CURRENT MEDICAL RESEARCH AND OPINION. - ISSN 0300-7995. - 32:2(2016), pp. 377-384. [10.1185/03007995.2015.1129321]

A pharmacological treatment algorithm for localised neuropathic pain [LNP]

ALLEGRI, Massimo;
2016-01-01

Abstract

Neuropathic pain is caused by a lesion or disease affecting the somatosensory system and is difficult to manage, often proving refractory to existing treatments. In more than half of cases, it is localised and affects a specific, clearly circumscribed area of the body (localised neuropathic pain, or LNP). A recently developed screening tool enables patients with probable neuropathic pain/LNP to be identified quickly and easily. In view of the conflicting current treatment recommendations, an advisory board of pain specialists met in June 2015 to develop a complementary treatment guidance algorithm, for use in the primary care setting and by non-pain specialists. The starting point of the algorithm is a diagnosis of LNP and there was consensus that first-line treatment should be a topical analgesic agent, because the benefit/risk ratios are far better than for systemic agents. Topical application offers site-specific delivery, a lower total systemic dose and avoidance of first-pass metabolism, reducing the risk of adverse events and drug/drug interactions. The 5% lidocaine medicated plaster has most evidence supporting its use in LNP, producing effective analgesia and reducing the associated area of allodynia, but other topical agents include capsaicin, clonidine and botulinum toxin type A. Treatment should be commenced with the topical agent of choice, and the patient re-assessed after an appropriate period. Where the response is good the topical agent is continued, with a re-evaluation after 3 to 6 months. A systemic agent (e.g. gabapentin, pregabalin, duloxetine, venlafaxine) is added if there is only a partial response, or substituted if there is no response, and the patient re-assessed after a month. If there is a poor or no response to the systemic agent the patient should be switched to an alternative one, and if this also proves ineffective referred to a pain specialist.
2016
A pharmacological treatment algorithm for localised neuropathic pain [LNP] / Allegri, Massimo; Baron, Ralf; Hans, Guy; Correa Illanes, Gerardo; Mayoral Rojals, Victor; Mick, Gerard; Serpell, Michael. - In: CURRENT MEDICAL RESEARCH AND OPINION. - ISSN 0300-7995. - 32:2(2016), pp. 377-384. [10.1185/03007995.2015.1129321]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2798534
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 54
  • ???jsp.display-item.citation.isi??? 41
social impact